Showing results (51-60 of 78) with videos related to
Sort By:
Pageof 8
Journal of Medical Virology|May 27, 2003
Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypesSimon Beddows, Sarah Galpin, Shamim H Kazmi, et al.The Journal of Infectious Diseases|September 30, 2025
Profiling Human Papillomavirus lineage-specific capsid antigenicity using geographically diverse natural infection antibodiesKavita Panwar, Kazutomo Yokoya, Sofia Gomes, et al.Journal of Virology|July 5, 2005
Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1Simon Beddows, Norbert Schülke, Marc Kirschner, et al.HIV Medicine|February 25, 2025
High-risk human papillomavirus prevalence and serostatus in a cohort of cisgender women and people with a cervix living with perinatally acquired HIVMerle Henderson, Dierdre Lyons, Simon Beddows, et al.Sexually Transmitted Infections|January 12, 2020
Antimicrobial resistance in <i>Mycoplasma genitalium</i> sampled from the British general populationRachel Pitt, Magnus Unemo, Pam Sonnenberg, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 22, 2025
Developing, validating and testing non-vaccine-preventable human papillomavirus to control for differences in sexual behaviour when evaluating HPV vaccinationEmily Dema, Jaimie Z Shing, Marta Checchi, et al.Virology|June 4, 2005
The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particlesCarolina Herrera, Per Johan Klasse, Elizabeth Michael, et al.Sexually Transmitted Infections|January 21, 2012
Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in BritainAnne M Johnson, Catherine H Mercer, Simon Beddows, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 22, 2007
Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohortPontiano Kaleebu, Immaculate L Nankya, David L Yirrell, et al.NPJ Vaccines|September 10, 2024
WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58Troy J Kemp, Gitika Panicker, Carina Eklund, et al.Pageof 8